Femasys Inc
NASDAQ:FEMY
Femasys Inc
Depreciation & Amortization
Femasys Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Femasys Inc
NASDAQ:FEMY
|
Depreciation & Amortization
-$483.5k
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Depreciation & Amortization
-$840m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-7%
|
|
Stryker Corp
NYSE:SYK
|
Depreciation & Amortization
-$627m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-15%
|
|
Abbott Laboratories
NYSE:ABT
|
Depreciation & Amortization
-$1.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-14%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Depreciation & Amortization
-$3.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Femasys Inc's Depreciation & Amortization?
Depreciation & Amortization
-483.5k
USD
Based on the financial report for Dec 31, 2023, Femasys Inc's Depreciation & Amortization amounts to -483.5k USD.
What is Femasys Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
11%
Over the last year, the Depreciation & Amortization growth was 14%. The average annual Depreciation & Amortization growth rates for Femasys Inc have been 11% over the past three years .